Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation”

1 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 1 of 1 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07712757
What this trial is testing

Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma

Who this might be right for
Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 MutationAstrocytoma IDH Mutant Grade 2Oligodendroglioma+2 more
Nuvation Bio Inc. 140